1,000 species get their genomes sequenced for the first time
A thousand reference genomes of the highest quality have now been produced for diverse eukaryotic species across the tree of life.
Careers | Find us | Contact us
2023-09-13T15:32:34+01:0014 September 2023|
A thousand reference genomes of the highest quality have now been produced for diverse eukaryotic species across the tree of life.
2023-09-11T16:06:43+01:0012 September 2023|
The Sanger Institute is committed to innovative science at scale, but we need partners and investors to transfer this science into the clinic. Mariya Chhatriwala, Business Development Manager, gives us her insights on how the Sanger Institute’s fifth spin-out company came to be.
2023-07-14T22:55:48+01:0012 July 2023|
Histologists, cardiologists, immunologists, cell biologists, software developers, bioinformaticians and specialist technicians have worked together to see individual cells in unprecedented detail. Using spatial genomics, they located each cell to its precise location in the heart.
2023-06-30T11:21:31+01:0026 June 2023|
Chenqu Suo looks back on her PhD, discussing her scientific highlights and her thoughts about what makes the Sanger Institute a special place to study.
2023-02-21T12:16:24+00:0021 February 2023|
Meet the first two winners of our new internal funding scheme to accelerate postdocs along their career trajectory
2023-01-12T12:11:55+00:0010 January 2023|
The Sanger Institute’s new Respiratory Virus and Microbiome Initiative will lead the way in developing the genomic tools and methodology to study and track a range of viruses and understand how they interact with the respiratory microbiome and human hosts.
2022-12-12T18:47:21+00:008 December 2022|
Meet the software developers, informaticians and bioinformaticians who are helping to sequence the DNA of all life on earth.
2022-11-03T12:56:59+00:003 November 2022|
Ben Lehner joins the Sanger Institute as a new Senior Group Leader. He seeks to lay the foundations for programmable biology.
2022-12-01T12:44:55+00:0019 October 2022|
Ian Dunham has been a pillar of Open Targets since its inception. Helena Cornu sat down with him to understand how his career led him from the Human Genome Project to Director of Open Targets, and what he envisions for the future of the consortium.‌
Wellcome Genome Campus,
Hinxton, Cambridgeshire,
CB10 1SA. UK
+44 (0)1223 834244
Wellcome Genome Campus,
Hinxton, Cambridgeshire, CB10 1SA. UK
+44 (0)1223 834244